Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Current Period Unauditd)

v3.23.1
Condensed Consolidated Balance Sheets (Current Period Unauditd) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 590,000 $ 2,482,000
Accounts receivable 3,463,000 6,134,000
Prepaid expense and other current assets 1,179,000 1,381,000
Total current assets 5,232,000 9,997,000
Property and Equipment, net 130,000 147,000
Intangible and Other Assets, net 19,040,000 20,066,000
Total assets 24,402,000 30,210,000
Current Liabilities    
Accounts payable 5,779,000 6,697,000
Accrued contingent consideration (Note 4) 3,674,000 3,206,000
Deferred revenue 29,000 111,000
Convertible note payable and accrued interest (Note 5) 0 679,000
Total current liabilities 9,482,000 10,693,000
Deferred taxes 313,000 313,000
Total liabilities 9,795,000 11,006,000
Commitments and Contingencies  
Stockholders’ Equity    
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; 12,622 and 10,323 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively (Note 6). 0 0
Common stock, par value $0.001 per share; 100,000,000 shares authorized; 37,795,077 and 37,605,973 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively. 47,000 47,000
Additional paid-in capital 232,539,000 229,900,000
Accumulated deficit (217,979,000) (210,743,000)
Total stockholders’ equity 14,607,000 19,204,000
Total liabilities and stockholders’ equity $ 24,402,000 $ 30,210,000